Twelve days after tumor challenge, we sacrificed tumor-bearing mice and analyzed tumor weights (Fig. 2A) and tumor-infiltrating DCs (Fig. 2B, C), the latter based on the expression of CD45, CD11c, CD11b, CD103, Ly6C and MHC-II markers. Here, PTPRC is linked to neoplasm.